Dr Wondwossen Gebreamanuel Tekle, MD - Medicare Neurology in Harlingen, TX

Dr Wondwossen Gebreamanuel Tekle, MD is a medicare enrolled "Psychiatry & Neurology - Neurology" physician in Harlingen, Texas. He graduated from medical school in 2001 and has 23 years of diverse experience with area of expertise as Neurology. He is a member of the group practice Bhs Physicians Network Inc and his current practice location is 2121 Pease Street, Suite 1d, Harlingen, Texas. You can reach out to his office (for appointments etc.) via phone at (956) 389-4060.

Dr Wondwossen Gebreamanuel Tekle is licensed to practice in Texas (license number P7216) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1417192808.

Contact Information

Dr Wondwossen Gebreamanuel Tekle, MD
2121 Pease Street, Suite 1d,
Harlingen, TX 78550
(956) 389-4060
Not Available



Physician's Profile

Full NameDr Wondwossen Gebreamanuel Tekle
GenderMale
SpecialityNeurology
Experience23 Years
Location2121 Pease Street, Harlingen, Texas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Wondwossen Gebreamanuel Tekle graduated from medical school in 2001
  NPI Data:
  • NPI Number: 1417192808
  • Provider Enumeration Date: 12/12/2008
  • Last Update Date: 06/13/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 4688820897
  • Enrollment ID: I20131011001388

Medical Identifiers

Medical identifiers for Dr Wondwossen Gebreamanuel Tekle such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1417192808NPI-NPPES
325672901MedicaidTX
P7216OtherTXMEDICAL LICENSE
313233YLLZOtherTXMEDICARE PTAN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084N0400XPsychiatry & Neurology - Neurology TRAINING (District Of Columbia)Secondary
2084N0400XPsychiatry & Neurology - Neurology P7216 (Texas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Vhs Harlingen Hospital Company LlcHarlingen, TXHospital
South Texas Health SystemEdinburg, TXHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Bhs Physicians Network Inc7315019593585

News Archive

WHO African Region now certified as wild polio-free after four years

Today, the Africa Regional Certification Commission certified the WHO African Region as wild polio-free after four years without a case. With this historic milestone, five of the six WHO regions – representing over 90% of the world's population – are now free of the wild poliovirus, moving the world closer to achieving global polio eradication.

WHO confirms 'emerging evidence' of airborne coronavirus

Scientists from around the world wrote a letter to the World Health Organization (WHO), urging the agency to acknowledge that the novel coronavirus is airborne. More than 230 scientists presented evidence that people can catch the virus from droplets floating in the air.

Disparities in managing depression among HIV-positive pregnant women

It seems logical that programs to screen and manage depression in pregnant, HIV-positive Medicaid patients should already be in place, but they aren't. It's the kind of glaring oversight that Rajesh Balkrishnan, associate professor at the University of Michigan College of Pharmacy, said he finds all the time in his research on health disparities.

Decision Resources forecasts sales of HER2-targeting agents to grow by 3.3% per year

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

A Phase 3 open-label study, recently published online by Pain Practice, has compared tapentadol extended release tablets, an investigational pain medication, to an existing prescription pain medication, oxycodone controlled release tablets.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Wondwossen Gebreamanuel Tekle allows following entities to bill medicare on his behalf.
Entity NameHarlingen Physician Network Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699726653
PECOS PAC ID: 1052212123
Enrollment ID: O20040120000931

News Archive

WHO African Region now certified as wild polio-free after four years

Today, the Africa Regional Certification Commission certified the WHO African Region as wild polio-free after four years without a case. With this historic milestone, five of the six WHO regions – representing over 90% of the world's population – are now free of the wild poliovirus, moving the world closer to achieving global polio eradication.

WHO confirms 'emerging evidence' of airborne coronavirus

Scientists from around the world wrote a letter to the World Health Organization (WHO), urging the agency to acknowledge that the novel coronavirus is airborne. More than 230 scientists presented evidence that people can catch the virus from droplets floating in the air.

Disparities in managing depression among HIV-positive pregnant women

It seems logical that programs to screen and manage depression in pregnant, HIV-positive Medicaid patients should already be in place, but they aren't. It's the kind of glaring oversight that Rajesh Balkrishnan, associate professor at the University of Michigan College of Pharmacy, said he finds all the time in his research on health disparities.

Decision Resources forecasts sales of HER2-targeting agents to grow by 3.3% per year

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

A Phase 3 open-label study, recently published online by Pain Practice, has compared tapentadol extended release tablets, an investigational pain medication, to an existing prescription pain medication, oxycodone controlled release tablets.

Read more Medical News

› Verified 4 days ago

Entity NameBhs Physicians Network Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1598958431
PECOS PAC ID: 7315019593
Enrollment ID: O20080703000069

News Archive

WHO African Region now certified as wild polio-free after four years

Today, the Africa Regional Certification Commission certified the WHO African Region as wild polio-free after four years without a case. With this historic milestone, five of the six WHO regions – representing over 90% of the world's population – are now free of the wild poliovirus, moving the world closer to achieving global polio eradication.

WHO confirms 'emerging evidence' of airborne coronavirus

Scientists from around the world wrote a letter to the World Health Organization (WHO), urging the agency to acknowledge that the novel coronavirus is airborne. More than 230 scientists presented evidence that people can catch the virus from droplets floating in the air.

Disparities in managing depression among HIV-positive pregnant women

It seems logical that programs to screen and manage depression in pregnant, HIV-positive Medicaid patients should already be in place, but they aren't. It's the kind of glaring oversight that Rajesh Balkrishnan, associate professor at the University of Michigan College of Pharmacy, said he finds all the time in his research on health disparities.

Decision Resources forecasts sales of HER2-targeting agents to grow by 3.3% per year

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

A Phase 3 open-label study, recently published online by Pain Practice, has compared tapentadol extended release tablets, an investigational pain medication, to an existing prescription pain medication, oxycodone controlled release tablets.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Wondwossen Gebreamanuel Tekle is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Wondwossen Gebreamanuel Tekle, MD
2209 Horseshoe Circle,
Harlingen, TX 78552

Ph: (571) 432-6314
Dr Wondwossen Gebreamanuel Tekle, MD
2121 Pease Street, Suite 1d,
Harlingen, TX 78550

Ph: (956) 389-4060

News Archive

WHO African Region now certified as wild polio-free after four years

Today, the Africa Regional Certification Commission certified the WHO African Region as wild polio-free after four years without a case. With this historic milestone, five of the six WHO regions – representing over 90% of the world's population – are now free of the wild poliovirus, moving the world closer to achieving global polio eradication.

WHO confirms 'emerging evidence' of airborne coronavirus

Scientists from around the world wrote a letter to the World Health Organization (WHO), urging the agency to acknowledge that the novel coronavirus is airborne. More than 230 scientists presented evidence that people can catch the virus from droplets floating in the air.

Disparities in managing depression among HIV-positive pregnant women

It seems logical that programs to screen and manage depression in pregnant, HIV-positive Medicaid patients should already be in place, but they aren't. It's the kind of glaring oversight that Rajesh Balkrishnan, associate professor at the University of Michigan College of Pharmacy, said he finds all the time in his research on health disparities.

Decision Resources forecasts sales of HER2-targeting agents to grow by 3.3% per year

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies - which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb - were the highest-selling drug class in breast cancer treatment.

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

A Phase 3 open-label study, recently published online by Pain Practice, has compared tapentadol extended release tablets, an investigational pain medication, to an existing prescription pain medication, oxycodone controlled release tablets.

Read more News

› Verified 4 days ago


Psychiatry & Neurology Doctors in Harlingen, TX

Kathleen Ann Salvatore, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 1713 Treasure Hills Blvd, Harlingen, TX 78550
Phone: 956-412-2700    Fax: 956-412-2701
Dr. Daniel Gustavo Herrera, MD, PH.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 1709 S 77 Sunshinestrip Ste B, Harlingen, TX 78550
Phone: 956-564-9510    Fax: 956-435-0215
Mikael S Muratoglu, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 2121 Pease St, Suite 1d, Harlingen, TX 78550
Phone: 956-389-4060    Fax: 956-412-7700
Terry Kimberg, CRNA
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 1702 N Ed Carey Dr, Harlingen, TX 78550
Phone: 956-423-4589    
Dr. Francisco Pascual Gomez, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 2902 Haine Drive, 3.144.06, Harlingen, TX 78550
Phone: 956-296-4000    Fax: 956-296-2842
Raissa Elaine Tanqueco,
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 2601 Veterans Dr, Harlingen, TX 78550
Phone: 956-291-9000    
J. Don Wathers, M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 1401 S Rangerville Rd, Harlingen, TX 78552
Phone: 956-364-8456    Fax: 956-364-8497

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.